Species distribution and antifungal susceptibility of clinical Aspergillus isolates: A multicentre study in Taiwan, 2016-2020

被引:1
|
作者
Wang, Hsuan-Chen [1 ]
Hsieh, Ming-, I [1 ]
Choi, Pui-Ching [1 ]
Wu, Wan-Lin [1 ]
Wu, Chi-Jung [1 ,2 ]
TSARM Hospitals
机构
[1] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, 5F,367 Sheng Li Rd, Tainan 70456, Taiwan
[2] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan
关键词
amphotericin B; antifungal Resistance; antifungal Susceptibility; Aspergillus; azoles; echinocandins; IN-VITRO ACTIVITY; AZOLE RESISTANCE; AMPHOTERICIN-B; FUMIGATUS; SUBSTITUTION; VORICONAZOLE; PHYLOGENY; INFECTION;
D O I
10.1111/myc.13593
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Epidemiological knowledge is important to guide antifungal therapy. Objective: This multicentre study aimed to investigate the species distribution and antifungal susceptibility of Aspergillus isolates in Taiwan. Method: Four hundred and ninety--two clinical Aspergillus isolates, collected during 2016--2020, were identified by calmodulin sequencing and tested for antifungal susceptibility using CLSI M38--A3. The Cyp51A sequences of azole--resistant Aspergillus fumigatus and Aspergillus flavus isolates were analysed. Results: This collection comprised 30 species from eight Aspergillus sections--Flavi (33.5%), Nigri (26.0%), Fumigati (24.2%), Terrei (10.0%), Nidulantes (5.1%), Circumdati (0.8%), Restricti (0.2%) and Aspergillus (0.2%). Sections Fumigati, Flavi and Terrei were primarily represented by A. fumigatus (99.2%), A. flavus (95.8%) and A. terreus (100%), respectively. Section Nigri comprised nine species, mostly A. welwitschiae (60.2%), A. niger (12.5%), A. brunneoviolaceus (10.9%) and A. tubingensis (10.2%). A. fumigatus (39.6%) and A. flavus ( 26.4%) p redominated a mong 5 3 i solates f rom l ower r espiratory samples, whereas section Nigri species (46.2%) and A. terreus (29.2%) predominated among 65 isolates from ear samples. Reduced susceptibility to amphotericin B (minimal inhibitory concentration (MIC) > 1 mu g/mL) was noted in A. flavus (7.0%), A. terreus (6.1%), A. nidulans and section Circumdati ( A. flocculosus, A. subramanianii and A. westerdijkiae) isolates. Acquired azole resistance was observed in seven A. fumigatus (5.9%), all of which carried TR34/L98H or TR34/L98H/S297T/F495I mutation, and three A. flavus (1.9%), one of which carried G441S mutation. Reduced susceptibility to itraconazole (MIC > 1 mu g/mL) was noted in 55.5% of section Nigri isolates, mainly in A. welwitschiae, A. niger and A. tubingensis, whereas A. brunneoviolaceus, A. aculeatinus and A. japonicus were hypersusceptible to azoles. Anidulafungin was active against all isolates except for one isolate. Conclusions: This study depicted the molecular epidemiology and species--specific characteristics of Aspergillus in Taiwan, which aids in appropriate antifungal therapy and underlines the need of speciation and susceptibility testing of disease- -causing Aspergillus.
引用
收藏
页码:711 / 722
页数:12
相关论文
共 50 条
  • [1] Species distribution and antifungal susceptibility of Aspergillus clinical isolates in Lebanon
    Osman, Marwan
    Bidon, Baptiste
    Abboud, Cynthia
    Zakaria, Ayate
    Hamze, Baraa
    Achcar, Marcel El
    Mallat, Hassan
    Dannaoui, Eric
    Dabboussi, Fouad
    Papon, Nicolas
    Bouchara, Jean-Philippe
    Hamze, Monzer
    [J]. FUTURE MICROBIOLOGY, 2021, 16 (01) : 13 - 26
  • [2] In vitro antifungal susceptibility of Aspergillus terreus species complex clinical isolates: a multicentre study in eight university hospitals
    Imbert, S.
    Normand, A. C.
    Ranque, S.
    Costa, J. M.
    Hennequin, C.
    Accoceberry, I.
    Bonnal, C.
    Houze, S.
    Fekkar, A.
    Bourgeois, N.
    Piarroux, R.
    Botterel, F.
    Dannaoui, E.
    [J]. MYCOSES, 2017, 60 : 67 - 68
  • [3] Multicentric Analysis of the Species Distribution and Antifungal Susceptibility of Clinical Isolates from Aspergillus Section Circumdati
    Imbert, S.
    Normand, A. C.
    Costa, D.
    Gabriel, F.
    Lachaud, L.
    Schuttler, C.
    Cassaing, S.
    Mahinc, C.
    Hasseine, L.
    Demar, M.
    Brun, S.
    Bonnal, C.
    Moreno-Sabater, A.
    Becker, P.
    Piarroux, R.
    Fekkar, A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (04)
  • [4] Antifungal susceptibility of clinical isolates of 25 genetically confirmed Aspergillus species collected from Taiwan and Mainland China
    Li, Ying
    Wang, He
    Zhao, Yu-Pei
    Xu, Ying-Chun
    Hsueh, Po-Ren
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (01) : 125 - 132
  • [5] Antifungal susceptibility of clinical isolates of 23 genetically confirmed Aspergillus species collected from Taiwan and Mainland China
    Li, Ying
    Wang, He
    Xu, Ying-Chun
    Hsueh, Po-Ren
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S31 - S32
  • [6] Species distribution and antifungal susceptibility patterns of Aspergillus isolates from clinical specimens and soil samples in Mexico
    Trevino-Rangel, Rogelio de J.
    Villanueva-Lozano, Hiram
    Bonifaz, Alexandro
    Castanon-Olivares, Laura R.
    Andrade, Angel
    Becerril-Garcia, Miguel A.
    Martinez-Resendez, Michel F.
    Ayala-Gaytan, Jacobo
    Montoya, Alexandra M.
    Gonzalez, Gloria M.
    [J]. MEDICAL MYCOLOGY, 2021, 59 (10) : 1006 - 1014
  • [7] Multicentre study of antifungal susceptibility patterns of yeast isolates and their species distributions in Bulgaria
    Ivanova, Z.
    Kantardjiev, T.
    Kouzmanov, A.
    Boyanova, L.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S659 - S659
  • [8] Species Identification and In Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Clinical Isolates from a French Multicenter Study
    Imbert, S.
    Normand, A. C.
    Ranque, S.
    Costa, J. M.
    Guitard, J.
    Accoceberry, I.
    Bonnal, C.
    Fekkar, A.
    Bourgeois, N.
    Houze, S.
    Hennequin, C.
    Piarroux, R.
    Dannaoui, E.
    Botterel, F.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (05)
  • [9] Antifungal susceptibility of clinical isolates of Scopulariopsis species
    Odero, Valle
    Garcia-Agudo, Lidia
    Guerrero, Inmaculada
    Aznar, Pilar
    Garcia-Martos, Pedro
    Rodriguez-lglesias, Manuel
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2014, 27 (01) : 17 - 21
  • [10] Multicentric Analysis of the Species Distribution and Antifungal Susceptibility of Cryptic Isolates from Aspergillus Section Fumigati
    Imbert, S.
    Normand, A. C.
    Cassaing, S.
    Gabriel, F.
    Kristensen, L.
    Bonnal, C.
    Lachaud, L.
    Costa, D.
    Guitard, J.
    Hasseine, L.
    Palous, M.
    Piarroux, M.
    Hendrickx, M.
    Piarroux, R.
    Fekkar, A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (12)